Brief: Knight Therapeutics And Helsinn Healthcare SA Enter Into Exclusive License, Distribution, And Supply Agreement For Akynzeo And Aloxi

Knight Therapeutics

12/05/2022 12:16

May 12 (Reuters) - Knight Therapeutics Inc  GUD.TO :
    * KNIGHT THERAPEUTICS AND HELSINN HEALTHCARE SA ENTER INTO
EXCLUSIVE LICENSE, DISTRIBUTION, AND SUPPLY AGREEMENT FOR
AKYNZEO® AND ALOXI®
    * KNIGHT - ENTERED LICENSE, DISTRIBUTION, SUPPLY DEAL FOR
AKYNZEO
ORAL/IV IN CANADA, BRAZIL, ARGENTINA, URUGUAY, PARAGUAY, AND
ALOXI ORAL/IV IN CANADA
    * KNIGHT THERAPEUTICS INC- WILL BEGIN COMMERCIAL ACTIVITIES
FOLLOWING A TRANSITION PERIOD FROM HELSINN'S CURRENT LICENSEES
    * KNIGHT THERAPEUTICS INC- FINANCIAL TERMS OF TRANSACTION
WERE NOT
DISCLOSED

Source text for Eikon:  ID:nGNX113mWk 
Further company coverage:  GUD.TO 

 ((Reuters.Briefs@thomsonreuters.com;))